Royce & Associates LP Decreases Stock Holdings in UFP Technologies, Inc. (NASDAQ:UFPT)

Royce & Associates LP lessened its holdings in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 44.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,949 shares of the industrial products company's stock after selling 7,293 shares during the quarter. Royce & Associates LP owned about 0.12% of UFP Technologies worth $2,834,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Congress Asset Management Co. boosted its holdings in UFP Technologies by 0.4% in the third quarter. Congress Asset Management Co. now owns 246,303 shares of the industrial products company's stock worth $78,004,000 after acquiring an additional 986 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of UFP Technologies by 2.6% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 105,118 shares of the industrial products company's stock worth $27,737,000 after buying an additional 2,699 shares during the last quarter. Swedbank AB bought a new stake in shares of UFP Technologies during the 1st quarter valued at about $25,220,000. Mountain Pacific Investment Advisers LLC boosted its holdings in shares of UFP Technologies by 0.3% in the third quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company's stock worth $29,445,000 after buying an additional 238 shares during the last quarter. Finally, Geneva Capital Management LLC grew its position in UFP Technologies by 0.3% during the third quarter. Geneva Capital Management LLC now owns 80,362 shares of the industrial products company's stock valued at $25,450,000 after buying an additional 243 shares during the period. Institutional investors own 87.28% of the company's stock.

Insider Transactions at UFP Technologies

In related news, CEO R Jeffrey Bailly sold 12,533 shares of the stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $346.46, for a total value of $4,342,183.18. Following the completion of the sale, the chief executive officer now directly owns 31,194 shares of the company's stock, valued at approximately $10,807,473.24. This represents a 28.66 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Ronald J. Lataille sold 4,798 shares of UFP Technologies stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $330.44, for a total transaction of $1,585,451.12. Following the transaction, the chief financial officer now directly owns 41,332 shares in the company, valued at $13,657,746.08. This represents a 10.40 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,516 shares of company stock worth $6,992,669 in the last three months. Corporate insiders own 6.17% of the company's stock.

UFP Technologies Stock Performance

UFPT stock traded up $11.55 during midday trading on Tuesday, reaching $290.49. 44,057 shares of the company's stock traded hands, compared to its average volume of 61,445. The stock's 50-day moving average is $308.59 and its 200 day moving average is $296.58. The stock has a market cap of $2.23 billion, a P/E ratio of 41.44 and a beta of 0.96. UFP Technologies, Inc. has a 52-week low of $152.43 and a 52-week high of $366.41. The company has a current ratio of 2.57, a quick ratio of 1.43 and a debt-to-equity ratio of 0.64.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.